Skip to main content
. 2001 Jan 6;322(7277):19. doi: 10.1136/bmj.322.7277.19

Table 4.

Intention to treat analysis of primary efficacy parameters in 55 participants during treatment periods of 12 weeks. Figures are means (SD)

Lisinopril Placebo Mean % reduction (95% CI)
Hours with headache 138 (130) 162 (134) 15 (0 to 30)
Days with headache 20.7 (14) 24.7 (11) 16 (5 to 27)
Days with migraine 14.6 (10) 18.7 (9) 22 (11 to 33)